PRETE, MARCELLA
 Distribuzione geografica
Continente #
NA - Nord America 4.526
EU - Europa 1.622
AS - Asia 637
Continente sconosciuto - Info sul continente non disponibili 5
SA - Sud America 4
OC - Oceania 3
AF - Africa 2
Totale 6.799
Nazione #
US - Stati Uniti d'America 4.524
IT - Italia 618
CN - Cina 409
SE - Svezia 402
SG - Singapore 152
UA - Ucraina 151
DE - Germania 125
FI - Finlandia 89
GB - Regno Unito 80
FR - Francia 78
IN - India 27
BE - Belgio 19
VN - Vietnam 16
CZ - Repubblica Ceca 14
IE - Irlanda 14
JP - Giappone 12
CH - Svizzera 6
EU - Europa 5
ID - Indonesia 4
NL - Olanda 4
AT - Austria 3
ES - Italia 3
HK - Hong Kong 3
IR - Iran 3
KR - Corea 3
AU - Australia 2
BG - Bulgaria 2
BR - Brasile 2
HR - Croazia 2
MD - Moldavia 2
NO - Norvegia 2
SA - Arabia Saudita 2
TR - Turchia 2
AL - Albania 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BJ - Benin 1
BZ - Belize 1
CA - Canada 1
CL - Cile 1
GR - Grecia 1
HU - Ungheria 1
IM - Isola di Man 1
KH - Cambogia 1
LT - Lituania 1
MA - Marocco 1
ME - Montenegro 1
MY - Malesia 1
NZ - Nuova Zelanda 1
PE - Perù 1
PL - Polonia 1
SY - Repubblica araba siriana 1
Totale 6.799
Città #
Chandler 609
Fairfield 444
Woodbridge 376
Jacksonville 366
Nyköping 339
Ashburn 315
Houston 303
Ann Arbor 215
Seattle 215
Cambridge 204
Wilmington 193
Bari 166
Singapore 115
Lawrence 105
Roxbury 104
Beijing 98
Nanjing 98
New York 92
Des Moines 71
Boardman 56
Princeton 49
Inglewood 44
Marseille 32
Milan 30
Brooklyn 28
Shenyang 27
Nanchang 23
Pune 23
Hebei 22
Los Angeles 22
Rome 21
Paris 20
San Diego 20
Brussels 19
Dearborn 19
Santa Clara 19
Dong Ket 16
Palermo 16
Noicattaro 14
Tianjin 14
Guangzhou 13
Jiaxing 12
Washington 12
Brno 11
London 11
Redwood City 11
Changsha 9
Munich 9
Auburn Hills 8
Dublin 7
Florence 7
Grafing 7
Helsinki 7
Wuhan 7
San Mateo 6
Kunming 5
Norwalk 5
Pontecorvo 5
Siena 5
Ancona 4
Edinburgh 4
Falls Church 4
Hefei 4
Indiana 4
Jinan 4
Messina 4
Ningbo 4
Osaka 4
Padova 4
Rho 4
San Francisco 4
Stimigliano 4
Wuxi 4
Ardabil 3
Arzano 3
Assèmini 3
Cascina 3
Claro 3
Fuzhou 3
Haikou 3
Incheon 3
Lacchiarella 3
Leawood 3
Lodi 3
Naples 3
Porto Recanati 3
Prescot 3
Reggio Emilia 3
Santa Maria Capua Vetere 3
Shanghai 3
Tappahannock 3
Triggiano 3
Verona 3
Waterford 3
Yiwu 3
Zhengzhou 3
Al Qatif 2
Amsterdam 2
Atlanta 2
Augusta 2
Totale 5.252
Nome #
L'immunoparesi nel mieloma multiplo 401
Evaluation of the influence of social, demographic, environmental, work-related factors and/or lifestyle habits on Raynaud's phenomenon: a case-control study 139
CD20-Mimotope Peptides: A Model to Define the Molecular Basis of Epitope Spreading 122
Clinical correlates of human leucocyte antigen (HLA)-G in systemic sclerosis 121
Anti-carbamylated protein antibodies and skin involvement in patients with systemic sclerosis: An intriguing association 121
Autoimmune uveitis: clinical, pathogenetic, and therapeutic features 117
Anti-centromere protein A antibodies in systemic sclerosis: Significance and origin 114
Early echocardiographic detection of left ventricular diastolic dysfunction in patients with systemic lupus erythematosus asymptomatic for cardiovascular disease 112
CD20-depleting therapy in autoimmune diseases: from basic research to the clinic 107
Clinical correlates of a subset of anti-CENP-A antibodies cross-reacting with FOXE3p53-62 in systemic sclerosis 105
Oxidized low density lipoproteins: The bridge between atherosclerosis and autoimmunity. Possible implications in accelerated atherosclerosis and for immune intervention in autoimmune rheumatic disorders. 105
Serum levels of beta-2-microglobulin-free heavy chain of HLA class I antigen in healthy individuals: relationship to their class I allotype 102
CD20-Mimotope Peptide Active Immunotherapy in Systemic Lupus Erythematosus and a Reappraisal of Vaccination Strategies in Rheumatic Diseases 102
Autoantibodies to intracellular antigens: generation and pathogenetic role 102
AB0695 Subspecificities of Anti-Centromeric-Associated Protein a (CENP-A) Antibodies (AB) Can Identified a Subset of Patients at Higher Risk of Developing Pulmonary Hypertension 95
Subspecificities of anticentromeric protein A antibodies identify systemic sclerosis patients at higher risk of pulmonary vascular disease 94
Vasculitides: Proposal for an integrated nomenclature 91
Autoimmune uveitis: a retrospective analysis of 104 patients from a tertiary reference center 89
Belimumab restores Treg/Th17 balance in patients with refractory systemic lupus erythematosus 89
Effectiveness and safety of belimumab in patients with active systemic lupus erythematosus: results from a large, nationwide, multicentric study. 87
CD20: A target antigen for immunotherapy of autoimmune diseases 85
Rheumatic disorders as paraneoplastic syndromes 85
Extra-articular manifestations of rheumatoid arthritis: an update 85
Working and safety profiles of JAK/STAT signaling inhibitors. Are these small molecules also smart? 84
Human CD4 internal antigen anti-idiotypic monoclonal antibody. Immunochemical and sequence analysis 83
Targeting angiogenesis in multiple myeloma by the VEGF and HGF blocking DARPin® protein MP0250: a preclinical study 83
Inhibition of mTOR complex 2 restrains tumor angiogenesis in multiple myeloma 80
null 77
Size variants of beta-2-microglobulin-free human leucocyte antigen class I heavy chain make different contributions to its serum increase in multiple myeloma 76
null 76
Increased serum levels of beta2m-free HLA class I heavy chain in multiple myeloma 75
Biological therapy with monoclonal antibodies: a novel treatment approach to autoimmune disease 72
Antiphospholipids syndrome complicated by a systemic capillary leak-like syndrome treated with steroids and intravenous immunoglobulins a case report 70
Early disease and low baseline damage predict response to belimumab in patients with systemic lupus erythematosus 70
B2 microglobulin-free heavy chain (FHC) of HLA class I antigen in patients with Hodgkin’s and non Hodgkin’s lymphomas 69
Severe pulmonary hypertension as the initial manifestation of systemic lupus erythematosus: a case report and review of the literature 64
Anti-carbamylated protein antibodies in patients with systemic sclerosis: an intriguing association with skin involvement 64
Beta2-m-free heavy chain levels of HLA-class I antigen combined with serum IgM or platelet count provide two reliable staging systems in multiple myeloma 61
Case series on amyloidosis and organ involvement: a single center experience 60
Analisi molecolare di un anticorpo monoclonale (ACMO) anti-idiotipo 'immagine interna' dell'antigene CD4 60
Beta2-microglobulin-free HLA class I heavy chain epitope mimicry by monoclonal antibody HC-10-specific peptide 59
SARS-CoV-2 infection complicated by inflammatory syndrome. Could high-dose human immunoglobulin for intravenous use (IVIG) be beneficial? 58
Identificazione del peptide che mima l'epitopo localizzato sulla catena pesante HLA-I non associata alla beta 2-microglobulina, riconosciuto dall'anticorpo monoclonale HC-10 57
Short-Term Variations in Neutrophil-to-Lymphocyte and Urea-to-Creatinine Ratios Anticipate Intensive Care Unit Admission of COVID-19 Patients in the Emergency Department 57
Staging multiple myeloma patients with active disease using serum levels of beta2m-free HLA class I heavy chain together with IgM or platelet count 56
Sars-cov-2 inflammatory syndrome. Clinical features and rationale for immunological treatment 56
Right Heart Changes Impact on Clinical Phenotype of Amyloid Cardiac Involvement: A Single Centre Study 54
The role of recombinant human erythropoietin alpha in the treatment of chronic anemia in multiple myeloma 53
Involvement of FAB subclass-specific determinants in the interaction of human IgG with Streptococcal Protein (PG) 52
International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren's syndrome)?: The unmet needs and the clinical grey zone in autoimmune disease management 52
Subclinical atherosclerosis and history of cardiovascular events in Italian patients with rheumatoid arthritis: Results from a cross-sectional, multicenter GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) study 50
Minimum structural requirement for CD4 mimicry by anti-idiotipic mAb 16D7 50
Anticorpi monoclonali nell'immunoterapia delle malattie autoimmuni 49
La neutropenia nei pazienti in trattamento: differenziazione dei fattori di crescita 48
Monoclonal antibodies (mAb) in the immunotherapy (IT) of autoimmune disease (AD) 47
Clinical use of erythropoietin 47
Beta-2 microglobulin-free HLA-A class I heavy chain (FHC) A3 and/or A30 soluble products contribute only minimally toserum FHC expression 47
Vasculiti primarie sistemiche 44
Anti Th/To autoantibodies: a predictor markers for interstitial lung disease in undifferentiated connective tissue disease at risk of systemic sclerosis 44
Mieloma multiplo e gammapatie monoclonali: quadri clinici, acquisizioni eziopatogenetiche e progressi terapeutici 43
null 42
Analisi molecolare di un anticorpo monoclonale (AcMo) anti-idiotipo “immagine interna” dell’antigene CD4 42
Constrictive pericarditis due to AL amyloidosis: a case report. 42
Dosaggio della catena pesante degli antigeni di Istocompatibilita' in pazienti con mieloma multiplo (MM) 41
BETA-2 microglobulin (beta2m)-free HLA Class I heavy chain as prognostic marker of multiple myeloma 40
Immunoparesisi in multiple myeloma 39
null 39
null 39
Beta 2-microglobulin-free heavy chain (FHC) of HLA class I antigen in patients with Hodgkin's and non-Hodgkin's lymphomas 38
null 38
Membrane-type metalloprotease activity and HLA class I mRNA splicing in generating tFHC variants in multiple myeloma: clinical significance 38
Amicrobial pustulosis or erosive pustular dermatosis of the inguinal folds: broad of the same spectrum? 38
null 37
Antibiotics or No Antibiotics, That Is the Question: An Update on Efficient and Effective Use of Antibiotics in Dental Practice 37
Ruolo degli autoanticorpi nelle patologie autoimmuni 36
null 36
Vasculiti primarie sistemiche 36
Epstein–Barr Virus in Salivary Samples from Systemic Lupus Erythematosus Patients with Oral Lesions 36
null 34
null 33
null 33
null 33
Echocardiographic alteration in patients with systemic lupus erythematosus affected by hepatic steatosis: a cross-sectional single center study 33
Monoclonal antibodies in the immunotherapy of autoimmune diseases 32
Serum levels of beta2-microglobulin-free heavy chain of HLA class I antigen are increased in patients with multiple myeloma. Role of FHC size variant 31
Biomolecular drugs in IBD: news, limits and perspective 30
Two structurally different peptides mimic a CD20 epitope recognized by rituximab 30
Functional characterization of peptides mimicking the CD20 epitope recognized by Rituximab 30
Serum levels of beta2-microglobulin-free heavy chain class I antigen are increased in patients with multiple myeloma. Role of FHC size variants 29
Clinical response and analysis of regulatory T cells (Tregs) in a cohort of patients with active Systemic Lupus Erythematosus (SLE) on treatment with belimumab. 29
Raynaud’s phenomenon: from molecular pathogenesis to therapy 29
An atypical presentation of intestinal neuroendocrine tumor. 29
Lupus vasculitis: An overview 29
Generation of linear and cyclic peptides revealed a unique fine specificity of Rituximab and its possible cross-reactivity with an acid sphingomyelinase-like phosphodiesterasem 3B precursor 28
Un esempio di mimotipo per l'iimunoterapia delle patologie autoimmuni 27
null 27
Dosaggio della catena pesante degli antigeni di istocompatibilità di classe I (HLA-I) nel siero di pazienti con mieloma multiplo 26
null 26
null 26
Presentazione atipica di tumore neuroendocrino intestinale 26
Totale 6.261
Categoria #
all - tutte 32.299
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.299


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.001 0 0 0 75 150 115 144 93 151 81 157 35
2020/20211.294 114 30 104 61 191 71 186 109 133 138 97 60
2021/2022816 35 88 6 34 28 66 60 46 39 43 143 228
2022/20231.563 196 207 116 143 171 219 34 181 220 11 46 19
2023/2024719 50 111 38 66 52 182 14 50 23 30 25 78
2024/2025319 92 27 195 5 0 0 0 0 0 0 0 0
Totale 7.163